Bixiye
Afrezza (regular human insulin, inhaled) - Commercial
Prior Authorization, Quantity Limit
Taariikhda uu dhaqangalayo Barnaamijka: : Abr 01, 2026
Natiijooyinka Raadinta
Soo bandhiga 4091 - 4100 ee natiijooyinka 4294
Bixiye
Hereditary Angioedema - Commercial
Prior Authorization, Quantity Limit
Taariikhda uu dhaqangalayo Barnaamijka: : Abr 01, 2026
Bixiye
Leqembi - Commercial
Prior Authorization, Quantity Limit
Taariikhda uu dhaqangalayo Barnaamijka: : Abr 01, 2026
Bixiye
Furoscix (furosemide) - Commercial
Prior Authorization, Quantity Limit
Taariikhda uu dhaqangalayo Barnaamijka: : Abr 01, 2026
Bixiye
Factor VIII and von Willebrand Factor - Commercial
Prior Authorization, Quantity Limit
Taariikhda uu dhaqangalayo Barnaamijka: : Abr 01, 2026
Bixiye
Duvyzat - Commercial
Prior Authorization, Quantity Limit
Taariikhda uu dhaqangalayo Barnaamijka: : Abr 01, 2026
Bixiye
Weight Management - Commercial
Prior Authorization, Quantity Limit
Taariikhda uu dhaqangalayo Barnaamijka: : Abr 01, 2026
Bixiye
Alternative Dosage Form - Commercial
Prior Authorization, Quantity Limit
Taariikhda uu dhaqangalayo Barnaamijka: : Abr 01, 2026
Bixiye
Saxenda Wegovy Zepbound - Commercial
Coverage Exception, Formulary Exception
Taariikhda uu dhaqangalayo Barnaamijka: : Abr 01, 2026